SOUTH SAN FRANCISCO, Calif., Oct. 16, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL), today announced that it will host a conference call and webcast for investors and analysts on Wednesday, October 23, 2019, at 10:00am Eastern Time. Members of Rigel's senior management team will provide an overv

ABBOTT PARK, Ill., Oct. 16, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2019.Third-quarter worldwide sales of $8.1 billion increased 5.5 percent on a reported basis and 7.6 percent on an organic* basis. Reported diluted EPS from continuing opera

JERSEY CITY, N.J., Oct. 16, 2019 /PRNewswire/ -- Lawsuit Settlement News announced today that they are preparing for an influx of hernia mesh lawsuits, and have set up a helpline for plaintiffs seeking legal assistance.The two most popular brands of hernia mesh are Johnson & Johnson's Ethicon Physiomesh and Atrium Medical Corporation's C-QUR. Both devices are

MARINA DEL REY, Calif., Oct. 16, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced the appointment of Heather Dale Jones, M.D. as its first Medical Director, f

REDWOOD CITY, Calif., Oct. 16, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced an upcoming presentation at the Annual Meeting of the American Society of Anesthesiologists.D

CRANBURY, N.J., Oct. 16, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) announced today that data from two pivotal, double-blind placebo-controlled Phase 3 trials (RECONNECT) and the Exit Survey/Interview data on Vyleesi™ (bremelanotide injection) for hypoactive sexual desire disorder (HSDD) will be presented at the 13th European So

SCHLIEREN, Switzerland, Oct. 16, 2019 /PRNewswire/ -- AL-S Pharma AG, a biotech company jointly founded and financed by Neurimmune and TVM Capital Life Science, announced today enrollment of the first patient in a multicenter Phase 1 clinical trial to evaluate AP-101 in patients with amyotrophic lateral sclerosis (ALS). AP-101 is a human antibody directed against misfold

NEW YORK, Oct. 16, 2019 /PRNewswire/ -- OTC Markets Group Inc.

CAMBRIDGE, Mass., Oct. 16, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, Chief Executive Officer, will present at the 2019 BIO Investor Forum on Wednesday,

MADRID, Oct. 16, 2019 /PRNewswire/ -- Pharmactive Biotech Products, S.L., launches its Affron® all-natural, non-GMO Spanish saffron extract (Crocus sativus L.) in the US market. The company's formulation boasts the lowest dosage threshold on the market — just